← Leaderboards
Ihab M Hajjar
Palmetto Health Richland
$22,834,610
Attributed
$27,389,417
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.1M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,053,363 · 14
By mechanism
RF1$12,721,974 · 3
R01$9,855,078 · 4
P30$6,885,873 · 3
K24$915,020 · 1
R56$801,525 · 1
K23$796,905 · 1
Top collaborators
- Arshed A Quyyumi3 shared
- Nicholas Thomas Seyfried1 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCognitiveS DiseaseBrainImpaired CognitionParticipantFutureHypertensionProgramsMild Cognitive ImpairmentNeuroimagingAreaAngiotensin ReceptorDementiaBiological MarkersCohortClinical TrialsBlood VesselsAmyloid Beta-ProteinAffectAgingTau ProteinsAngiotensin IiBase
Grant awards (36)
North Texas ADRC$4,663,946
P30 · FY2025 · AG · contact PI
North Texas ADRC - Clinical Core$1,259,069
P30 · FY2025 · AG · contact PI
Post COVID-19 Neuro-Cognitive Manifestations and Underlying Mechanisms in Older African Americans$1,177,717
R01 · FY2025 · AG · contact PI
North Texas ADRC - Admin Core$962,858
P30 · FY2025 · AG · contact PI
Digital Biomarkers for Alzheimerâs Disease$811,479
R01 · FY2024 · AG · contact PI
Mid-Career Program for Vascular Contributions to Alzheimer's disease$183,004
K24 · FY2024 · AG · contact PI
Digital Biomarkers for Alzheimerâs Disease$833,195
R01 · FY2023 · AG · contact PI
Mid-Career Program for Vascular Contributions to Alzheimer's disease$183,004
K24 · FY2023 · AG · contact PI
Post COVID-19 Neuro-Cognitive Manifestations and Underlying Mechanisms in Older African Americans$3,612,360
RF1 · FY2022 · AG · contact PI
Digital Biomarkers for Alzheimerâs Disease$778,931
R01 · FY2022 · AG · contact PI
Mid-Career Program for Vascular Contributions to Alzheimer's disease$183,004
K24 · FY2022 · AG · contact PI
Digital Biomarkers for Alzheimerâs Disease$40,899
R01 · FY2022 · AG · contact PI
Digital Biomarkers for Alzheimers Disease$801,525
R56 · FY2021 · AG · contact PI
Mid-Career Program for Vascular Contributions to Alzheimer's disease$183,004
K24 · FY2021 · AG · contact PI
Digital Biomarkers for Alzheimerâs Disease$158,926
R01 · FY2021 · AG · contact PI
Mid-Career Program for Vascular Contributions to Alzheimer's disease$183,004
K24 · FY2020 · AG · contact PI
A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer$779,538
R01 · FY2019 · AG · contact PI
A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer$701,583
R01 · FY2018 · AG · contact PI
Building a high-resolution multi-omic AD interactome with the AMP-AD and M2OVE-AD Projects$3,079,393
RF1 · FY2017 · AG · contact PI
A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer$773,972
R01 · FY2017 · AG · contact PI
Hypertension angiotensin receptor blockers and cognition: effects and mechanism$585,100
R01 · FY2017 · AG · contact PI
The role of the renin-angiotensin-endothelial pathway in AD$298,038
RF1 · FY2017 · AG · contact PI
A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer$752,394
R01 · FY2016 · AG · contact PI
Hypertension angiotensin receptor blockers and cognition: effects and mechanism$598,521
R01 · FY2016 · AG · contact PI
Community based assessments regarding vascular contributions to Alzheimers Disease in M2OVE AD consortium$497,270
RF1 · FY2016 · AG · contact PI
The role of the renin-angiotensin-endothelial pathway in AD$5,234,913
RF1 · FY2015 · AG · contact PI
Hypertension angiotensin receptor blockers and cognition: effects and mechanism$598,586
R01 · FY2014 · AG · contact PI
Hypertension angiotensin receptor blockers and cognition: effects and mechanism$605,719
R01 · FY2013 · AG · contact PI
Hypertension, angiotensin receptor blockers, and cognition: effects and mechanism$658,518
R01 · FY2012 · AG · contact PI
Aging and The Renin-Angiotensin System in Elderly Hypertensive Individuals$159,381
K23 · FY2011 · AG · contact PI
Aging and The Renin-Angiotensin System in Elderly Hypertensive Individuals$93,168
K23 · FY2010 · AG · contact PI
Aging and The Renin-Angiotensin System in Elderly Hypertensive Individuals$66,213
K23 · FY2010 · AG · contact PI
Aging and The Renin-Angiotensin System in Elderly Hypertensive Individuals$159,381
K23 · FY2009 · AG · contact PI
Aging and The Renin-Angiotensin System in Elderly Hypertensive Individuals$159,381
K23 · FY2008 · AG · contact PI
Aging and The Renin-Angiotensin System in Elderly Hypertensive Individuals$159,381
K23 · FY2007 · AG · contact PI
Geriatricweb: The Geriatric Digital Library Project$76,988
G07 · FY2002 · LM